Skeletal muscle sarcomere function in health and disease
Skeletal muscle sarcomere function in health and disease
批准号:
10445504
负责人:
JOSEPH Mark METZGER
金额:
$54.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-01 至 2027-04-30
关键词:
AddressArthrogryposisBiosensorBreathingCharacteristicsChemosensitizationContractile ProteinsContractureDataDiseaseDistalFluorescence Resonance Energy TransferFunctional disorderGeneticHealthHumanHyperactivityInheritedLongevityMemoryMicrofilamentsMissionModelingMolecular ConformationMovementMuscleMuscle WeaknessMuscle functionMuscular DystrophiesMyopathyMyosin ATPaseNemaline MyopathiesPerformancePersonal SatisfactionPharmaceutical PreparationsPhosphorylationPhysiologicalProcessRegulationReportingRoleSarcomeresSignal TransductionSkeletal MuscleStimulusStriated MusclesStructureSystemTestingTherapeutic InterventionThin FilamentTimeTropomyosinTroponinUnited States National Institutes of HealthWalkingbasebiophysical analysiseffective therapyinnovationmechanical loadmechanotransductionmyosin-binding protein Cnovelnovel therapeuticspreventpublic health relevancerestorationsensorskeletalsmall moleculestemtargeted treatmenttool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Skeletal muscle accounts for 40% of body mass and defines in significant ways who we are as human beings.
From the essential underpinnings of breathing, to the basic day-to-day movements of sitting, standing, and
walking, skeletal muscle function enables the fullness of the human condition. Numerous skeletal muscle
diseases cause marked contractile dysfunction leading to significantly diminished overall wellbeing and lifespan
in humans. Therefore, preventing or reversing muscle dysfunction has significant health relevance. This proposal
focuses on the sarcomere - the functional unit of striated muscle – known to underlie multiple forms of contractile
dysfunction. In Nemaline myopathy, severe muscle weakness arises from hypoactive sarcomeres, while the
severe muscle contractures characteristic of Distal Arthrogryposis stem from hyperactive sarcomeres. Other
disorders, including inherited Muscular dystrophies, also involve altered sarcomere function. These diseases
establish the sarcomere as a crucial, yet highly underserved, target for therapeutic intervention. Skeletal muscle
diseases involving defective sarcomeres have no cure or effective treatments. A major challenge to progress
centers on the inherent complexities of sarcomere regulation. Recently, novel ON/OFF myosin cross-bridge
activation states under mechano-sensing regulatory control have been proposed to interface with the troponin-
tropomyosin system to regulate contraction. Working together, through dynamic inter-myofilament signaling, this
new view of sarcomere regulation has significant implications for muscle health and disease. To date, the data
supporting this model derives mainly from biophysical studies, with physiological relevance unclear and critical
to elucidate. We developed and validated a novel FRET-based sarcomere activation biosensor integrated into
the myofilaments of intact skeletal muscle. Preliminary data shows the biosensor detects conformational
changes in troponin, serving as a signaling nexus for real time reporting load-dependent inter-myofilament
signaling regulation of sarcomere activation during physiological contractions in live skeletal muscles. Guiding
hypothesis: Healthy skeletal muscle function requires precise sarcomere activation accomplished by dynamic
inter-myofilament signaling wherein thin filament regulation initiates and myosin sustains sarcomere activation
during physiological contraction; consequently, defective inter-myofilament signaling causes disease. The Aims
are to investigate physiological mechanisms of inter-myofilament signaling in regulating sarcomere activation
during twitch contractions in intact skeletal muscles and to investigate the effects myosin binding protein C as a
key mechano-sensor governing inter-myofilament signaling processes in regulating sarcomere activation during
twitch contractions in intact skeletal muscles. Elucidating the mechanisms underlying physiologically relevant
mechano-sensitive inter-myofilament signaling will provide the essential framework for advancing new
therapeutic discoveries to retain healthy skeletal muscle performance throughout lifespan, and to restore normal
skeletal muscle function in inherited myopathies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inclusive Excellence Training Program in the Systems Biology of Cardiovascular Inflammation
-
批准号:10555753
-
项目类别:
-
资助金额:$20.62万
-
财政年份:2023
-
负责人:JOSEPH Mark METZGER
-
依托单位:
Skeletal muscle sarcomere function in health and disease
-
批准号:10655541
-
项目类别:
-
资助金额:$53.11万
-
财政年份:2022
-
负责人:JOSEPH Mark METZGER
-
依托单位:
Copolymer-Based Sarcolemma Stabilization for Protecting Dystrophic Skeletal Muscles in Vivo
-
批准号:10153697
-
项目类别:
-
资助金额:$45.23万
-
财政年份:2018
-
负责人:JOSEPH Mark METZGER
-
依托单位:
Copolymer-Based Sarcolemma Stabilization for Protecting Dystrophic Skeletal Muscles in Vivo
-
批准号:9923445
-
项目类别:
-
资助金额:$46.63万
-
财政年份:2018
-
负责人:JOSEPH Mark METZGER
-
依托单位:
Copolymer-Based Sarcolemma Stabilization for Protecting Dystrophic Skeletal Muscles in Vivo
-
批准号:10403499
-
项目类别:
-
资助金额:$46.17万
-
财政年份:2018
-
负责人:JOSEPH Mark METZGER
-
依托单位:
Dystrophin and Heart Disease
-
批准号:9367436
-
项目类别:
-
资助金额:$38.08万
-
财政年份:2017
-
负责人:JOSEPH Mark METZGER
-
依托单位:
Myofilaments as regulators of heart function in disease
-
批准号:10364296
-
项目类别:
-
资助金额:$55.14万
-
财政年份:2017
-
负责人:JOSEPH Mark METZGER
-
依托单位:
Myofilaments as regulators of heart function in disease
-
批准号:9902505
-
项目类别:
-
资助金额:$38.31万
-
财政年份:2017
-
负责人:JOSEPH Mark METZGER
-
依托单位:
Myofilaments as regulators of heart function in disease
-
批准号:9311335
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2017
-
负责人:JOSEPH Mark METZGER
-
依托单位:
Myofilaments as regulators of heart function in disease
-
批准号:10544034
-
项目类别:
-
资助金额:$55.36万
-
财政年份:2017
-
负责人:JOSEPH Mark METZGER
-
依托单位:
Targeted membrane integrity in cardiac ischemia and reperfusion
-
批准号:10421054
-
项目类别:
-
资助金额:$63.23万
-
财政年份:2014
-
负责人:JOSEPH Mark METZGER
-
依托单位:
Targeted membrane integrity in cardiac ischemia and reperfusion
-
批准号:8962165
-
项目类别:
-
资助金额:$65.45万
-
财政年份:2014
-
负责人:JOSEPH Mark METZGER
-
依托单位:
Targeted membrane integrity in cardiac ischemia and reperfusion
-
批准号:9180719
-
项目类别:
-
资助金额:$65.45万
-
财政年份:2014
-
负责人:JOSEPH Mark METZGER
-
依托单位:
Targeted membrane integrity in cardiac ischemia and reperfusion
-
批准号:9976559
-
项目类别:
-
资助金额:$63.23万
-
财政年份:2014
-
负责人:JOSEPH Mark METZGER
-
依托单位:
Dystrophin Function in Aging Heart
-
批准号:8659327
-
项目类别:
-
资助金额:$34.47万
-
财政年份:2010
-
负责人:JOSEPH Mark METZGER
-
依托单位:
Dystrophin Function in Aging Heart
-
批准号:7886262
-
项目类别:
-
资助金额:$34.81万
-
财政年份:2010
-
负责人:JOSEPH Mark METZGER
-
依托单位:
Dystrophin Function in Aging Heart
-
批准号:8236955
-
项目类别:
-
资助金额:$34.47万
-
财政年份:2010
-
负责人:JOSEPH Mark METZGER
-
依托单位:
Dystrophin Function in Aging Heart
-
批准号:8061648
-
项目类别:
-
资助金额:$34.47万
-
财政年份:2010
-
负责人:JOSEPH Mark METZGER
-
依托单位:
Dystrophin Function in Aging Heart
-
批准号:8437208
-
项目类别:
-
资助金额:$32.57万
-
财政年份:2010
-
负责人:JOSEPH Mark METZGER
-
依托单位:
Chemical-based membrane sealants for dystrophic muscle
-
批准号:7321479
-
项目类别:
-
资助金额:$46.27万
-
财政年份:2007
-
负责人:JOSEPH Mark METZGER
-
依托单位:
海外基金